ClinicalTrials.gov
public full text
Public Domain
OPTIMIZE IDE for the Treatment of ACS
Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System#811594
- EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries#866407
- Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery#904308
- Small Coronary Artery Treated by TAXUS Liberté Registry in Japan#912630
- Dynamic Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease#1164509
Record · ID 852894
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive